Regenxbio Inc. (RGNX) PT Raised to $145 at Chardan Capital Markets
Tweet Send to a Friend
Chardan Capital Markets analyst Gbola Amusa raised the price target on Regenxbio Inc. (NASDAQ: RGNX) to $145.00 (from $127.50) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
